Related Experiment Video
Updated: Dec 5, 2025
Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
Published on: February 20, 2015
Complement Activation on Endothelial Cell-Derived Microparticles-A Key Determinant for Cardiovascular Risk in
Naomi Martin1,2, Xiaodie Tu1,2, Alicia J Egan1
1Faculty of Health and Life Sciences, De Montfort University, Leicester LE1 9BH, UK.
Insights
Systemic lupus erythematosus (SLE) patients have increased cardiovascular risk due to circulating microparticles. Analyzing these microparticles may identify ethnic groups at higher risk for cardiovascular complications.
Area of Science:
- Immunology
- Cardiology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease impacting multiple organs.
- SLE involves complement overactivation, immune-complex deposition, vasculitis, and thrombosis risk.
- Cardiovascular disease is a significant, often life-limiting, complication in SLE patients.
Purpose of the Study:
- To highlight the role of circulating microparticles in SLE pathophysiology.
- To propose microparticle analysis as a tool for cardiovascular risk stratification in SLE.
- To identify specific ethnic groups with elevated cardiovascular risk in SLE.
Main Methods:
- Review of existing literature on SLE, microparticles, and cardiovascular risk.
- Discussion of the pathophysiological mechanisms linking microparticles to thrombosis and inflammation.
- Proposal for a new approach to risk assessment based on microparticle characteristics.
Main Results:
- Circulating microparticles are implicated in SLE pathogenesis, particularly thrombosis.
- Microparticles represent a known cardiovascular risk factor in the general population and in SLE.
- Analysis of microparticle profiles may offer insights into differential cardiovascular risk among SLE patients.
Conclusions:
- Circulating microparticles are key players in the cardiovascular complications of SLE.
- Monitoring microparticle characteristics could refine cardiovascular risk assessment in SLE.
- This approach may help identify high-risk ethnic groups needing targeted interventions for cardiovascular disease prevention.
Abstract:
Systemic lupus erythematosus is a classical systemic autoimmune disease that overactivates complement and can affect all organs. Early diagnosis and effective management are important in this immune-complex-mediated chronic inflammatory disease, which has a strong component of vasculitis and carries an increased risk of thrombosis, even in the absence of antiphospholipid antibodies. Development of lupus nephritis can be life limiting but is managed with dialysis and renal transplantation. Therefore, data have become available that cardiovascular risk poses a serious feature of systemic lupus erythematosus that requires monitoring and prospective treatment. Cell-derived microparticles circulate in plasma and thereby intersect the humoral and cellular component of inflammation. They are involved in disease pathophysiology, particularly thrombosis, and represent a known cardiovascular risk. This viewpoint argues that a focus on characteristics of circulating microparticles measured in patients with systemic lupus erythematosus may help to classify certain ethnic groups who are especially at additional risk of experiencing cardiovascular complications.
More Related Videos
Related Concept Videos
01:27Complement System
01:26Coronary Artery Disease II: Pathophysiology
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Peripheral Artery Disease I: Introduction